---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-030375"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T19:28:50.304762+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Globus Medical to acquire NuVasive in all-stock merger; each NuVasive share gets 0.75 GMED share

## Summary
- Each NuVasive share converted into 0.75 Globus Medical Class A common shares; no cash consideration except fractional shares.
- Expected close by Oct 8, 2023, extendable to Feb 8, 2024; subject to HSR, shareholder approvals, and other conditions.
- Termination fees: NuVasive pays $120M (reduced to $75M in Specified Period); Globus pays $120M in certain scenarios.
- Globus board expanded to 11 members; 3 NuVasive directors to be appointed post-close.
- David & Sonali Paul (70% voting power) agree to vote Globus Class B shares in favor of issuance.

## SEC filing metadata
- accession: 0001193125-23-030375
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/0001193125-23-030375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/d447800d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-030375
- JSON: https://secwatch.observer/filing/0001193125-23-030375.json
- Plain text: https://secwatch.observer/filing/0001193125-23-030375.txt

## Key facts
- Material Agreements
  GLOBUS MEDICAL INC entered into Agreement and Plan of Merger with NuVasive, Inc. (effective 2023-02-08).
  - Action: entry
  - Agreement: merger
  - Counterparty: NuVasive, Inc.
  - Effective: 2023-02-08
  source text: On February 8, 2023, NuVasive, Inc., a Delaware corporation (“NuVasive”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Globus Medical, Inc., a Delaware corporation (“Globus Medical”) and Zebra Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Globus Medical (“Merger Sub”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/0001193125-23-030375-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.